EFL054 - Renal Protection of Metformin
Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism providing data in support of…
Read the full article1y agoen
You might also wanna read
GLP-1 vs SGLT2: The New Frontier in Diabetes Therapy
A new commentary in The Lancet examines whether oral GLP-1 receptor agonists can match SGLT2 inhibitors in cardiovascular and kidney protect
thepolarisreport.com·6d ago
SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial
Conditions : Kidney Transplant Recipient; Sodium Glucose Co-Transporter 2 Inhibitors; Non-Diabetic Patients; Randomized Controlled Trial (RC
clinicaltrials.gov·14d ago
Researchers Reverse Kidney Damage in Mice by Targeting Ceramide-Induced Mitochondrial Damage
Researchers uncovered how fatty molecules called ceramides trigger acute kidney injury by damaging the mitochondria that power kidney cells.
sciencedaily.com·8mo ago
Research Suggests Heart Disease, Kidney Disease and Type 2 Diabetes May Be One Condition Treatable with GLP-1 Drugs
These three disorders could really be “CKM syndrome,” which can be treated with drugs like Ozempic
scientificamerican.com·7mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.